Development and Validation of a Carbohydrate Metabolism-Related Model for Predicting Prognosis and Immune Landscape in Hepatocellular Carcinoma Patients.

Autor: Huang HX; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.; Jiangxi Institute of Respiratory Disease, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China., Zhong PY; Department of Oncology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, 330006, China., Li P; Jiangxi Institute of Respiratory Disease, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China., Peng SJ; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China., Ding XJ; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China., Cai XL; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China., Chen JH; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China., Zhu X; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China., Lu ZH; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China., Tao XY; Jiangxi Institute of Respiratory Disease, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China.; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China., Liu YY; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China. liuyyeyhl@163.com., Chen L; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China. clmedic@126.com.

Publikováno v: Current medical science [Curr Med Sci] 2024 Aug; Vol. 44 (4), pp. 771-788. Date of Electronic Publication: 2024 Aug 03.

Guided vs. conventional anti-platelet therapy for patients with acute coronary syndrome: A meta-analysis of randomized controlled trials.

Autor: Zhong PY; Department of Cardiology, Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College, Nanchong, China., Deng JP; Department of Cardiology, Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College, Nanchong, China., Zhao JH; Department of Cardiology, Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College, Nanchong, China., Peng L; Department of Urology, The Second Hospital of Lanzhou University Medical School, Lanzhou, China.; South China Hospital, Health Science Center, Shenzhen University, Shenzhen, China., Liu T; Department of Cardiology, Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College, Nanchong, China., Wang HY; Department of Cardiology, Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College, Nanchong, China.

Publikováno v: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2023 Mar 21; Vol. 10, pp. 1079332. Date of Electronic Publication: 2023 Mar 21 (Print Publication: 2023).

Efficacy and Safety of De-escalation of Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Meta-Analysis of Randomized Clinical Trials.

Autor: Bai N; The First Clinical Medical College, Lanzhou University, Lanzhou, China; and., Ma Y; The First Clinical Medical College, Lanzhou University, Lanzhou, China; and., Niu Y; The First Clinical Medical College, Lanzhou University, Lanzhou, China; and., Zhong PY; The First Clinical Medical College, Lanzhou University, Lanzhou, China; and., Shang YS; The First Clinical Medical College, Lanzhou University, Lanzhou, China; and., Wang ZL; Department of Cardiology, The First Hospital of Lanzhou University, Lanzhou, China.

Publikováno v: Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 2022 Aug 01; Vol. 80 (2), pp. 226-235. Date of Electronic Publication: 2022 Aug 01.

Efficacy and Safety of Proton Pump Inhibitors in Patients With Coronary Artery Diseases Receiving Oral Antiplatelet Agents and/or Anticoagulants: A Systematic Review and Meta-Analysis.

Autor: Shang YS; The First Clinical Medical College of Lanzhou University, Lanzhou, China ; and., Zhong PY; The First Clinical Medical College of Lanzhou University, Lanzhou, China ; and., Ma Y; The First Clinical Medical College of Lanzhou University, Lanzhou, China ; and., Bai N; The First Clinical Medical College of Lanzhou University, Lanzhou, China ; and., Niu Y; The First Clinical Medical College of Lanzhou University, Lanzhou, China ; and., Wang ZL; Department of Cardiology, The First Hospital of Lanzhou University, Lanzhou, China.

Publikováno v: Journal of cardiovascular pharmacology [J Cardiovasc Pharmacol] 2022 Jul 01; Vol. 80 (1), pp. 1-12. Date of Electronic Publication: 2022 Jul 01.

Evaluate Short-Term Outcomes of abciximab in ST-Segment Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Clinical Trials.

Autor: Bai N; The First Clinical Medical College of Lanzhou University, Lanzhou, China., Niu Y; The First Clinical Medical College of Lanzhou University, Lanzhou, China., Ma Y; The First Clinical Medical College of Lanzhou University, Lanzhou, China., Shang YS; The First Clinical Medical College of Lanzhou University, Lanzhou, China., Zhong PY; The First Clinical Medical College of Lanzhou University, Lanzhou, China., Wang ZL; Department of Cardiology, The First Hospital of Lanzhou University, Lanzhou, China.

Publikováno v: Journal of interventional cardiology [J Interv Cardiol] 2022 May 29; Vol. 2022, pp. 3911414. Date of Electronic Publication: 2022 May 29 (Print Publication: 2022).